Mutual of America Capital Management’s Kennedy-Wilson Holdings KW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,730
Closed -$149K 1471
2026
Q1
$149K Buy
13,730
+18
+0.1% +$187 ﹤0.01% 1337
2025
Q4
$133K Buy
13,712
+273
+2% +$2.45K ﹤0.01% 1339
2025
Q3
$112K Sell
13,439
-1,839
-12% -$14.8K ﹤0.01% 1331
2025
Q2
$104K Sell
15,278
-1,931
-11% -$12.9K ﹤0.01% 1354
2025
Q1
$149K Sell
17,209
-692
-4% -$6.31K ﹤0.01% 1376
2024
Q4
$179K Buy
17,901
+127
+0.7% +$1.39K ﹤0.01% 1395
2024
Q3
$196K Sell
17,774
-1,440
-7% -$15.3K ﹤0.01% 1399
2024
Q2
$187K Sell
19,214
-1,198
-6% -$11.2K ﹤0.01% 1405
2024
Q1
$175K Sell
20,412
-326
-2% -$3.21K ﹤0.01% 1424
2023
Q4
$257K Sell
20,738
-28
-0.1% -$351 ﹤0.01% 1351
2023
Q3
$306K Sell
20,766
-2,376
-10% -$38.4K ﹤0.01% 1247
2023
Q2
$378K Sell
23,142
-977
-4% -$15.6K ﹤0.01% 1211
2023
Q1
$400K Buy
+24,119
New +$411K ﹤0.01% 1189

Other funds holding KW

Mutual of America Capital Management's KW Position: Q2 2026 in Review

Mutual of America Capital Management sold out of Kennedy-Wilson Holdings (KW) in Q2 2026, closing a stake of 13,730 shares — an estimated $149K sold.

Mutual of America Capital Management first reported a position in KW in Q1 2023 and held it in 13 quarters. The position peaked at $400K in Q1 2023. 2 funds tracked by Wall St. Rank hold KW as of Q2 2026.

  • Mutual of America Capital Management reported no remaining Kennedy-Wilson Holdings position as of Q2 2026 after selling out during the quarter.
  • Mutual of America Capital Management sold 13,730 Kennedy-Wilson Holdings shares in Q2 2026, an estimated $149K.
  • Mutual of America Capital Management first reported a position in Kennedy-Wilson Holdings in Q1 2023 and held it in 13 quarters.
  • Mutual of America Capital Management's Kennedy-Wilson Holdings position peaked at $400K in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Kennedy-Wilson Holdings as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.